Zami Aberman, CEO & Chairman at PLURISTEM THERAPEUTICS INC (PSTI), bought 25,000 shares at $2.07 ($53K) on 2015-09-15, disclosed to the SEC on 2015-09-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.07 | 10,000 | $21K | 39.2% |
| 2 | $2.13 | 10,000 | $21K | 40.4% |
| 3 | $2.15 | 5,000 | $11K | 20.4% |
| Total | $2.11 avg | 25,000 | $53K | 100% |
| Filing → |
| PSTI | BUY | 2019-04-08 | $100K | — | Filing → |
| PSTI | BUY | 2016-02-24 | $7K | — | Filing → |
| PSTI | BUY | 2016-02-17 | $16K | — | Filing → |